Health ❯ Healthcare

Biotechnology

Drug Development Clinical Trials Gene Therapy Cancer Treatment Pharmaceuticals Gene Editing Therapeutics Clinical Research Immunotherapy Vaccine Development

UCB to Buy Candid Therapeutics for Up to $2.2 Billion

The buyout expands UCB's push into T‑cell engager drugs for autoimmune diseases.

CNS Pharmaceuticals Soars 215% on $22.5 Million Oversubscribed Private Placement

Class Action Filed Against Atara Biotherapeutics Over Alleged Misstatements on FDA Setbacks

Moderna Beats Q1 Forecast as Overseas COVID Shot Sales Rebound

Gilead Closes $7.8 Billion Arcellx Deal to Take Full Control of Anito‑cel

FDA Approves First Gene Therapy for Inherited Hearing Loss

CG Oncology Rallies After Pivotal Bladder Cancer Data Tops Expectations

Eli Lilly to Buy Kelonia for Up to $7 Billion to Gain In‑Vivo CAR‑T Platform

First-in-Human SynKIR-110 Shows Safe Profile and Early Activity in Solid Tumors

Clearmind’s AUD Candidate Meets Early Safety Goal as Shares Double

Alger Mid Cap Fund Reports Q1 Lag as AI Shift and Oil Shock Recast Portfolio Drivers

Kailera Leaps 62% in Nasdaq Debut After $625 Million IPO

Atara Investors Get May 22 Deadline to Seek Lead Role in Securities Suit

FDA Grants Orphan Drug Status to Immutep’s Efti for Soft Tissue Sarcoma

Transgene Completes Phase 2 Randomization for Personalized Cancer Vaccine TG4050

Jeito Capital Closes $1.2 Billion Second Fund in Claimed European Biopharma Record

CRISPR Therapeutics’ Pipeline Pitched as Path to One-Time Heart Risk Treatments

ImmunityBio Faces Growing Securities Suits After FDA Flags Misleading Anktiva Claims

SCYNEXIS Acquires Poxel’s PXL-770 for ADPKD, Plans 2026 Phase 2 Trial

GSK Gains After Cramer Endorsement as Company Pushes Into Weight-Loss Drugs